Literature DB >> 25484791

Crystal structure of 6-chloro-5-iso-propyl-pyrimidine-2,4(1H,3H)-dione.

Nadia G Haress1, Hazem A Ghabbour1, Ali A El-Emam2, C S Chidan Kumar3, Hoong-Kun Fun4.   

Abstract

In the mol-ecule of the title compound, C7H9ClN2O2, the conformation is determined by intra-molecular C-H⋯O and C-H⋯Cl hydrogen bonds, which generate S(6) and S(5) ring motifs. The isopropyl group is almost perpendicular to the pyrimidine ring with torsion angles of -70.8 (3) and 56.0 (3)°. In the crystal, two inversion-related mol-ecules are linked via a pair of N-H⋯O hydrogen bonds into R 2 (2)(8) dimers; these dimers are connected into chains extending along the bc plane via an additional N-H⋯O hydrogen bond and weaker C-H⋯O hydrogen bonds. The crystal structure is further stabilized by a weak π-π inter-action [3.6465 (10) Å] between adjacent pyrimidine-dione rings arranged in a head-to-tail fashion, producing a three-dimensional network.

Entities:  

Keywords:  crystal structure; hydrogen bonds; pyrimidine-2,4-dione; π–π inter­action

Year:  2014        PMID: 25484791      PMCID: PMC4257309          DOI: 10.1107/S1600536814021382

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of pyrimidine-2,4(1H,3H)-diones, see: Miyasaka et al. (1989 ▶); Tanaka et al. (1995 ▶); Hopkins et al. (1996 ▶); El-Brollosy et al. (2009 ▶); Klein et al. (2001 ▶); Nencka et al. (2006 ▶); El-Emam et al. (2004 ▶). For the use of 5-alkyl-6-chloro­pyrimidine-2,4(1H,3H)-diones in synthesis, see: El-Emam et al. (2004 ▶). For related pyrimidine-2,4-dione structures, see: El-Brollosy et al. (2011 ▶); Al-Omary et al. (2014 ▶); Haress et al. (2014 ▶). For the synthesis of the title compound, see: Al-Turkistani et al. (2011 ▶); Koroniak et al. (1993 ▶). For hydrogen-bond motifs, see: Bernstein et al. (1995 ▶).

Experimental

Crystal data

C7H9ClN2O2 M = 188.61 Monoclinic, a = 11.2244 (4) Å b = 6.8288 (3) Å c = 11.6641 (5) Å β = 104.577 (2)° V = 865.26 (6) Å3 Z = 4 Cu Kα radiation μ = 3.62 mm−1 T = 296 K 0.45 × 0.28 × 0.26 mm

Data collection

Bruker APEXII CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.292, T max = 0.458 5647 measured reflections 1553 independent reflections 1444 reflections with I > 2σ(I) R int = 0.027

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.114 S = 1.06 1553 reflections 122 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.27 e Å−3 Δρmin = −0.32 e Å−3

Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S1600536814021382/sj5429sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814021382/sj5429Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S1600536814021382/sj5429Isup3.cml Click here for additional data file. . DOI: 10.1107/S1600536814021382/sj5429fig1.tif The mol­ecular structure of the title compound with atom labels and 30% probability displacement ellipsoids. Click here for additional data file. . DOI: 10.1107/S1600536814021382/sj5429fig2.tif Crystal packing of the title compound, showing the hydrogen bonding inter­actions as dashed lines. H-atoms not involved in the hydrogen bonding are omited for clarity. CCDC reference: 1026350 Additional supporting information: crystallographic information; 3D view; checkCIF report
C7H9ClN2O2F(000) = 392
Mr = 188.61Dx = 1.448 Mg m3
Monoclinic, P21/cCu Kα radiation, λ = 1.54178 Å
Hall symbol: -P 2ybcCell parameters from 3341 reflections
a = 11.2244 (4) Åθ = 3.9–69.4°
b = 6.8288 (3) ŵ = 3.62 mm1
c = 11.6641 (5) ÅT = 296 K
β = 104.577 (2)°Block, colourless
V = 865.26 (6) Å30.45 × 0.28 × 0.26 mm
Z = 4
Bruker APEXII CCD diffractometer1553 independent reflections
Radiation source: fine-focus sealed tube1444 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.027
φ and ω scansθmax = 69.7°, θmin = 4.1°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −12→13
Tmin = 0.292, Tmax = 0.458k = −8→7
5647 measured reflectionsl = −13→10
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.040H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.114w = 1/[σ2(Fo2) + (0.0664P)2 + 0.3263P] where P = (Fo2 + 2Fc2)/3
S = 1.06(Δ/σ)max < 0.001
1553 reflectionsΔρmax = 0.27 e Å3
122 parametersΔρmin = −0.32 e Å3
0 restraintsExtinction correction: SHELXL, Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.0181 (15)
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl10.20279 (5)0.71985 (9)0.34179 (6)0.0644 (3)
O10.55744 (12)0.3674 (2)0.28760 (12)0.0465 (4)
O20.35879 (13)0.0719 (2)0.53323 (13)0.0522 (4)
N10.39383 (14)0.5227 (2)0.32786 (14)0.0386 (4)
N20.45727 (14)0.2261 (2)0.41291 (14)0.0394 (4)
C10.29636 (16)0.5181 (3)0.37878 (16)0.0371 (4)
C20.47498 (15)0.3710 (3)0.33892 (15)0.0354 (4)
C30.36295 (16)0.2134 (3)0.46972 (15)0.0371 (4)
C40.27390 (15)0.3729 (3)0.44806 (15)0.0368 (4)
C50.16037 (17)0.3635 (3)0.49593 (17)0.0437 (5)
C60.1871 (2)0.3338 (5)0.6280 (2)0.0697 (7)
H6A0.24380.43220.66750.105*
H6B0.22260.20650.64800.105*
H6C0.11190.34370.65270.105*
C70.0719 (2)0.2127 (5)0.4302 (3)0.0815 (9)
H7A0.05680.23550.34650.122*
H7B−0.00410.22170.45330.122*
H7C0.10650.08450.44860.122*
H1N10.403 (2)0.617 (4)0.2856 (19)0.043 (6)*
H1N20.506 (2)0.132 (4)0.422 (2)0.059 (7)*
H50.125 (2)0.489 (4)0.481 (2)0.058 (7)*
U11U22U33U12U13U23
Cl10.0662 (4)0.0486 (4)0.0892 (5)0.0249 (2)0.0395 (3)0.0243 (3)
O10.0481 (7)0.0421 (8)0.0587 (9)0.0001 (6)0.0307 (6)−0.0012 (6)
O20.0522 (8)0.0506 (9)0.0614 (9)0.0157 (6)0.0286 (6)0.0227 (7)
N10.0458 (8)0.0321 (8)0.0424 (9)0.0018 (6)0.0197 (7)0.0042 (6)
N20.0394 (8)0.0381 (8)0.0451 (9)0.0095 (7)0.0187 (7)0.0061 (6)
C10.0392 (9)0.0358 (9)0.0379 (10)0.0053 (7)0.0124 (7)−0.0011 (7)
C20.0373 (8)0.0343 (9)0.0365 (9)−0.0012 (7)0.0129 (7)−0.0044 (7)
C30.0376 (9)0.0394 (10)0.0361 (10)0.0033 (7)0.0125 (7)0.0025 (7)
C40.0380 (9)0.0393 (10)0.0346 (9)0.0044 (7)0.0120 (7)0.0005 (7)
C50.0420 (9)0.0460 (11)0.0485 (11)0.0095 (8)0.0215 (8)0.0060 (8)
C60.0585 (13)0.108 (2)0.0512 (14)0.0016 (14)0.0296 (11)−0.0019 (13)
C70.0472 (13)0.120 (3)0.0849 (19)−0.0208 (14)0.0314 (13)−0.0335 (17)
Cl1—C11.7200 (18)C4—C51.516 (2)
O1—C21.222 (2)C5—C71.500 (3)
O2—C31.226 (2)C5—C61.507 (3)
N1—C21.364 (2)C5—H50.95 (3)
N1—C11.370 (2)C6—H6A0.9600
N1—H1N10.83 (2)C6—H6B0.9600
N2—C21.360 (2)C6—H6C0.9600
N2—C31.386 (2)C7—H7A0.9600
N2—H1N20.84 (3)C7—H7B0.9600
C1—C41.342 (3)C7—H7C0.9600
C3—C41.457 (2)
C2—N1—C1121.92 (16)C7—C5—C6111.5 (2)
C2—N1—H1N1117.6 (15)C7—C5—C4110.49 (17)
C1—N1—H1N1120.4 (15)C6—C5—C4114.38 (17)
C2—N2—C3126.87 (16)C7—C5—H5109.6 (16)
C2—N2—H1N2116.1 (17)C6—C5—H5106.3 (15)
C3—N2—H1N2116.9 (17)C4—C5—H5104.3 (15)
C4—C1—N1124.69 (16)C5—C6—H6A109.5
C4—C1—Cl1123.17 (14)C5—C6—H6B109.5
N1—C1—Cl1112.13 (13)H6A—C6—H6B109.5
O1—C2—N2123.07 (17)C5—C6—H6C109.5
O1—C2—N1122.60 (17)H6A—C6—H6C109.5
N2—C2—N1114.32 (15)H6B—C6—H6C109.5
O2—C3—N2119.22 (16)C5—C7—H7A109.5
O2—C3—C4124.43 (16)C5—C7—H7B109.5
N2—C3—C4116.35 (16)H7A—C7—H7B109.5
C1—C4—C3115.60 (16)C5—C7—H7C109.5
C1—C4—C5123.76 (16)H7A—C7—H7C109.5
C3—C4—C5120.54 (16)H7B—C7—H7C109.5
C2—N1—C1—C43.4 (3)N1—C1—C4—C5−175.22 (17)
C2—N1—C1—Cl1−175.53 (14)Cl1—C1—C4—C53.6 (3)
C3—N2—C2—O1−176.48 (18)O2—C3—C4—C1177.94 (19)
C3—N2—C2—N14.4 (3)N2—C3—C4—C1−2.5 (2)
C1—N1—C2—O1175.02 (17)O2—C3—C4—C5−5.7 (3)
C1—N1—C2—N2−5.8 (2)N2—C3—C4—C5173.89 (16)
C2—N2—C3—O2179.34 (18)C1—C4—C5—C7105.3 (2)
C2—N2—C3—C4−0.3 (3)C3—C4—C5—C7−70.8 (3)
N1—C1—C4—C31.0 (3)C1—C4—C5—C6−128.0 (2)
Cl1—C1—C4—C3179.85 (13)C3—C4—C5—C656.0 (3)
D—H···AD—HH···AD···AD—H···A
N1—H1N1···O1i0.83 (3)2.01 (3)2.833 (2)169 (2)
N2—H1N2···O2ii0.83 (3)2.03 (3)2.854 (2)171 (2)
C5—H5···Cl10.94 (3)2.57 (2)3.132 (2)118.7 (17)
C6—H6A···O1iii0.962.563.455 (3)156
C6—H6B···O20.962.453.034 (3)119
Table 1

Hydrogen-bond geometry (, )

DHA DHHA D A DHA
N1H1N1O1i 0.83(3)2.01(3)2.833(2)169(2)
N2H1N2O2ii 0.83(3)2.03(3)2.854(2)171(2)
C5H5Cl10.94(3)2.57(2)3.132(2)118.7(17)
C6H6AO1iii 0.962.563.455(3)156
C6H6BO20.962.453.034(3)119

Symmetry codes: (i) ; (ii) ; (iii) .

  11 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors.

Authors:  A L Hopkins; J Ren; R M Esnouf; B E Willcox; E Y Jones; C Ross; T Miyasaka; R T Walker; H Tanaka; D K Stammers; D I Stuart
Journal:  J Med Chem       Date:  1996-04-12       Impact factor: 7.446

3.  A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.

Authors:  T Miyasaka; H Tanaka; M Baba; H Hayakawa; R T Walker; J Balzarini; E De Clercq
Journal:  J Med Chem       Date:  1989-12       Impact factor: 7.446

4.  Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase.

Authors:  Radim Nencka; Ivan Votruba; Hubert Hrebabecký; Eva Tloust'ová; Kveta Horská; Milena Masojídková; Antonín Holý
Journal:  Bioorg Med Chem Lett       Date:  2005-12-05       Impact factor: 2.823

5.  Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1.

Authors:  Nasser R El-Brollosy; Omar A Al-Deeb; Ali A El-Emam; Erik B Pedersen; Paolo La Colla; Gabriella Collu; Giuseppina Sanna; Roberta Loddo
Journal:  Arch Pharm (Weinheim)       Date:  2009-11       Impact factor: 3.751

6.  Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.

Authors:  H Tanaka; H Takashima; M Ubasawa; K Sekiya; N Inouye; M Baba; S Shigeta; R T Walker; E De Clercq; T Miyasaka
Journal:  J Med Chem       Date:  1995-07-21       Impact factor: 7.446

7.  6-(3,5-Dimethyl-benz-yl)-5-ethyl-1-[(2-phen-oxy-eth-oxy)meth-yl]-1,2,3,4-tetra-hydro-pyrimidine-2,4-dione.

Authors:  Nasser R El-Brollosy; Ali A El-Emam; Omar A Al-Deeb; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-05

8.  5-Propyl-6-(p-tolyl-sulfan-yl)pyrimidine-2,4(1H,3H)-dione.

Authors:  Fatmah A M Al-Omary; Hazem A Ghabbour; Ali A El-Emam; C S Chidan Kumar; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-01-22

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20

10.  6-[(2-Methyl-phen-yl)sulfan-yl]-5-propyl-pyrimidine-2,4(1H,3H)-dione.

Authors:  Nadia G Haress; Hazem A Ghabbour; Ali A El-Emam; C S Chidan Kumar; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.